Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02047214
Title Safety and Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cortice Biosciences, Inc.
Indications

glioblastoma

Therapies

Bevacizumab + Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.